FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies

Therapies targeting MAPK and AKT/mTOR signaling are currently being evaluated in clinical trials for several tumor types. However, recent studies suggest that these therapies may be limited due to acquired cancer cell resistance and a small therapeutic index between normal and cancer cells. The iden...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Cipriano, Rocky, Miskimen, Kristy L.S., Bryson, Benjamin L., Foy, Chase R., Bartel, Courtney A., Jackson, Mark W.
التنسيق: Artigo
اللغة:Inglês
منشور في: Impact Journals LLC 2013
الموضوعات:
Research Papers
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742833/
https://ncbi.nlm.nih.gov/pubmed/23676467
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة